Abstract:Myopia has long been a global threat to public health. Timely interventions are likely to reduce the risk of vision-threatening complications. There are both established and rapidly evolving therapeutic approaches to slow myopia progression and/or delay its onset. The effective methods for slowing myopia progression include atropine eye-drops, defocus incorporated multiple segments (DIMS) spectacle lenses, spectacle lenses with highly aspherical lenslets target (HALT), diffusion optics technology (DOT) spectacle lenses, red light therapy (RLT), multifocal soft contact lenses and orthokeratology. Among these, 0.05% atropine, HALT lenses, RLT and +3.00 peripheral addition soft contact lenses yield over 60% reduction in myopia progression, whereas DIMS, DOT and MiSight contact lenses demonstrate at least 50% myopia control efficacy. 0.05% atropine demonstrates a more optimal balance of efficacy and safety than 0.01%. The efficacy of 0.01% atropine has not been consistent and requires further validation across diverse ethnicities. Combining atropine 0.01% with orthokeratology or DIMS spectacles yields better outcomes than using these interventions as monotherapies. Increased outdoor time is an effective public health strategy for myopia prevention while recent studies suggest that 0.05% low-concentration atropine and RLT therapy have promising potential as clinical myopia prevention interventions for high-risk groups. Myopia control spectacle lenses, being the least invasive, are safe for long-term use. However, when considering other approaches, it is essential to ensure proper instruction and regular follow-ups to maintain safety and monitor any potential complications. Ultimately, significant advances have been made in myopia control strategies, many of which have shown meaningful clinical outcomes. However, regular use and adequate safety monitoring over extended durations are imperative to foster confidence that can only come from extensive clinical experience.

Strengthening research on high myopia

Strengthening the understanding of the pathological evolution of myopia

Vision for the future: pioneering strategies in China's battle against myopia

Current Situation and Thinking of Prevention and Control of Myopia among Children and Adolescents in China

IMI Prevention of Myopia and Its Progression

Advances in biomedical study of the myopia-related signaling pathways and mechanisms

Artificial intelligence and digital solutions for myopia

Challenges and Future Development of Myopia Imaging

Research progress on the interaction between myopia and visual cortex

Epidemiology of Myopia

Advances in myopia control strategies for children

New progress of myopia prevention and control in adolescents

Deep Learning-Based Health Management Model Application in Extreme Myopia Eye Vision Monitoring and Risk Prediction

Advances in research on myopic traction maculopathy

Animal models as windows into the pathogenesis of myopia: Illuminating new directions for vision health

High Myopia Detection Method on Fundus Images Based on Curriculum Learning

Research advances in the animal models and pathogenic mechanisms of myopia

Molecular Mechanisms and Interference Strategies of Glaucoma and Myopia

Research advance in optic disc tilt and rotation in high myopia and its implications for glaucoma and visual field defects

Complications of high myopia: An update from clinical manifestations to underlying mechanisms

[Advances on Optic Disc Morphological Features and Peripapillary Structure Changes in High Myopia].